New Safety Requirements in the Treatment of Asthma

  • Wed, 6/30/10 - 12:52pm
  • 0 Comments
  • 559 reads

This First Report provides an overview of the FDA's recommendations on the appropriate use of long-acting beta-agonists and the value of low-dose inhaled corticosteroid monotherapy in the treatment of asthma.

image description image description